ESNT vs UTHR · P/E 8.2, rev $698.8M vs P/E 20, rev $1.56B
Essent Group Ltd (ESNT) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Essent Group Ltd (ESNT) is a insurance - specialty company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ESNT revenue for 2026-06-30 was $698.8M. Net income was $361.5M. ESNT currently screens at market cap $5.33B and trailing P/E 8.2.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ESNT currently screens at market cap $5.33B and trailing P/E 8.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ESNT and UTHR stock pages for the full models.
Not investment advice.